key: cord-1010795-ef7863vt
authors: Beddok, Arnaud; Calugaru, Valentin; Minsat, Mathieu; Dendale, Rémi; De Oliveira, Aurélien; Costa, Émilie; Goudjil, Farid; Belshi, Rezart; Pierrat, Noelle; Rochas, Christophe; Gravigny, Anne Catherine; Soisick, Lucas; Fleury, Hélène Colella; Créhange, Gilles
title: Post-lockdown management of oncological priorities and postponed radiation therapy following the COVID-19 pandemic: Experience of the institut curie
date: 2020-06-05
journal: Radiother Oncol
DOI: 10.1016/j.radonc.2020.05.043
sha: c8a0f5e2ba471fc1199c55215da4c93248418a26
doc_id: 1010795
cord_uid: ef7863vt

• During COVID-19 lockdown, the number of radiotherapy treatments had to be reduced. • Given number of delayed treatments, the post-crisis period should be anticipated. • Data visualization software allowed to predict when peak activity would happen.

In France, as in most countries, strict strategies were implemented in cancer hospitals to reduce the spread of coronavirus (COVID-19), but to maintain as much as possible the capacity of oncology health services [1, 2] . These strategies included the reduction of elective services, an emphasis on remote visits, and the use of personal protective equipment [3] [4] [5] [6] [7] . International radiation therapy (RT) academic societies proposed to restrict the indications for treatment [8] , to delay as long as possible the start of non-urgent treatments and to prefer hypofractionated regimens [9] [10] [11] [12] [13] [14] [15] [16] . To our knowledge, none of these recommendations anticipated how to handle the load of delayed treatments after the lockdown. However, the successful management of cancer treatments during lockdown undoubtedly correlates with the successful management of post-lockdown activity overload.

The Institut Curie has one of the largest RT departments in Europe. It is spread over three separate sites in the Paris area and has a total of eleven LINACs (six in Paris, four in Saint-Cloud and one in Orsay) and three treatment rooms for proton therapy in Orsay. In 2019, 5,860 patients were treated and the average number of treatment sessions per month delivered was 8,931, comprising 4,183 sessions in Paris, 3,303 in Saint-Cloud and 1445 in Orsay. In order to comply with the international recommendations mentioned above, several measures had to be applied in our department to protect both patients and operators from the risk of contamination. The challenges of post-crisis management following the COVID-19 pandemic therefore had to be anticipated. Here, we propose some key considerations to prepare for the post-lockdown period by presenting the guidelines adopted by the RT department of the Institut Curie.

During the French lockdown (in France from 17/03/20 to 11/05/20), priorities were established in order to limit the number of treatments. All indications for exclusive RT, whether or not combined with concomitant chemotherapy, were initiated without delay. These indications included not-yetresected tumors (head and neck cancer, neurological cancer including glioblastoma, lung cancer, pediatric cancer, etc.), but excluded prostate cancer and metastatic tumours requiring local treatment, whatever the primary. Preoperative RT, stereotactic body RT, gynecological brachytherapy and proton therapy were provided throughout the lockdown without modifying the delay and the number of sessions (except for rectal cancer, i.e. 5X5Gy). For breast cancer patients that had already begun RT and patients for whom irradiation (either for breast cancer or palliative treatment) was about to be started (planning in progress or completed but treatment not started), the number of sessions was adapted, giving priority to hypofractionation (workflow "adapt-COVID") [17] . For patients whose treatment was not yet planned and whose start could be postponed for a few months, a new workflow called "break-COVID" was created and used to: (1) evaluate and identify the patients with delayed interventions during the crisis (delayed CT-scans, delayed treatment starts); (2) ensure the qualitative follow-up of delayed cases; (3) ensure the qualitative and quantitative follow-up of prescription changes; (4) resume treatment starts when the crisis is over by pushing forward the cases that were ready to start. The supplementary data 1 summarizes the fractionation and delay adjustments. It should be noted that specialized procedures such as isocentric lateral decubitus irradiation and Deep Inspiration Breath Hold for breast cancers, and brachytherapy for prostate cancers were suspended.

Similarly, the use of spirometry for respiratory gating in lung cancers was temporarily abandoned and replaced by 4D scanners in order to avoid handling high-risk components, such as breathing filters, to limit the risk of contamination as much as possible. Moreover, COVID+ patients were all treated on a dedicated machine, in prone position, using free-breathing VMAT technique and daily CBCT-based repositioning delivered on a Halcyon  (Varian  , PaloAlto, California). In this RT room, strict hygiene guidelines were established for all patients and operators. A dedicated circuit using a dedicated elevator and with arrows on the floor was set up in the RT department to avert contact between COVID+ and COVID-patients. We have used InSightive  software (Varian  ) to provide a detailed analysis of all postponed treatments, and the projected evolution of the activity, i.e. the number of sessions per day in the RT department, during the periods before French lockdown, during lockdown, and following lockdown, respectively ( Figure 1) . Therefore, the treatment strategy was changed for 333 patients ( Finally, we highlighted some of the key issues in anticipating the end of COVID-19 crisis in a high-volume department of RT in a French comprehensive cancer center, and analyzed the use of certain techniques that could be continued outside the epidemic context, such as hypofractionation, and obtaining real-time data monitoring using data visualization tools. 

The official French guidelines to protect patients with cancer against SARS-CoV-2 infection

Impact of nonpharmaceutical interventions (NPIs) to reduce COVID-19 mortality and healthcare demand 2020

COVID-19 OUTBREAK IN NORTHERN ITALY: FIRST PRACTICAL INDICATIONS FOR RADIOTHERAPY DEPARTMENTS

Running a Radiation Oncology Department at the time of coronavirus: an Italian experience

A segregated-team model to maintain cancer care during the COVID-19 outbreak at an academic center in Singapore

Outbreak on Radiation Oncology in Taiwan

First statement on preparation for the COVID-19 pandemic in large German Speaking University-based radiation oncology departments

Radiotherapy in the time of the Coronavirus pandemic: when less is better

International Guidelines on Radiation Therapy for Breast Cancer During the COVID-19 Pandemic

Practice recommendations for lung cancer radiotherapy during the COVID-19 pandemic: An ESTRO-ASTRO consensus statement

Recommendations for Triage, Prioritization and Treatment of Breast Cancer Patients During the COVID-19 Pandemic

COVID-19: Global radiation oncology's targeted response for pandemic preparedness

International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic

ILROG Emergency Guidelines for Radiation Therapy of Hematological Malignancies During the COVID-19

Practice recommendations for risk-adapted head and neck cancer radiotherapy during the COVID-19 pandemic: an ASTRO-ESTRO consensus statement

Prostate Cancer Radiation Therapy Recommendations in Response to COVID-19